PamelaIHartzbandMD
Endocrinology • Boston, MAPituitary Disorders & Neuroendocrinology, Thyroid
Assistant Professor of Medicine, Beth Israel Deaconess Medical Center
Dr. Hartzband is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-9344Fax+1 617-667-7060
Summary
- Dr. Pamela Hartzband is an endocrinologist in Boston, MA and is affiliated with Beth Israel Deaconess Medical Center. She received her medical degree from Harvard Medical School and has been in practice 39 years. She specializes in pituitary disorders & neuroendocrinology and thyroid. She has more than 30 publications and over 500 citings.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1983- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1980 - 1981
Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1980
Harvard Medical SchoolClass of 1978
Certifications & Licensure
CA State Medical License 1980 - Present
MA State Medical License 1984 - 2025
NH State Medical License 2024 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Thyroid nodules and cancer: The search for certainty.Pamela Hartzband
Cancer Cytopathology. 2024-12-01 - 5 citationsRisk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveill...Elizabeth A Hall, Pamela Hartzband, Paul A VanderLaan, Michiya Nishino
Cancer Cytopathology. 2023-05-01 - 5 citationsCombined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance.Allison M. Onken, Paul A. VanderLaan, James V. Hennessey, Pamela Hartzband, Michiya Nishino
Cancer Cytopathology. 2021-07-27
Press Mentions
A Proposal on Healthcare: Strengthening the Party’s ProgramJune 22nd, 2021- Physician Burnout Requires Systemic SolutionsJuly 21st, 2020
- Your NEJM Group Today: Easing MD Burnout / Triple Inhaled Therapy for COPD / Card. & Neuro. OpportunitiesJune 25th, 2020
- Join now to see all
Professional Memberships
- Member
- Endocrine SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
